Sharon Banin

Title: Innovations by Sharon Banin

Introduction

Sharon Banin is a notable inventor based in London, GB. She has made significant contributions to the field of biotechnology, particularly in the development of methods for detecting enzymes and viability-associated molecules. With a total of 2 patents, her work has important applications in diagnostics and toxicology.

Latest Patents

Sharon's latest patents include "Methods and kits for detecting an enzyme capable of modifying a nucleic acid" and "Methods of detecting viability-associated molecules." The first patent describes an improved method for detecting an enzyme that modifies nucleic acids, enhancing the sensitivity of immunoassays and diagnosing specific conditions. The preferred enzyme in this method is a phosphatase. The second patent outlines a method for detecting molecules associated with the viability of cells, utilizing an enzyme that generates a novel detectable nucleic acid molecule. This method has applications in monitoring cell viability and toxicology testing, with ATP being a key molecule associated with viability.

Career Highlights

Sharon Banin is currently associated with Iseao Technologies Limited, where she continues to innovate in her field. Her work has garnered attention for its practical applications in various scientific and medical domains.

Collaborations

Sharon has collaborated with notable colleagues, including Stuart Mark Wilson and John Christopher Stanley, contributing to the advancement of their shared research goals.

Conclusion

Sharon Banin's innovative work in enzyme detection and cell viability monitoring showcases her significant impact on biotechnology. Her patents reflect her commitment to advancing scientific knowledge and improving diagnostic methods.